絞り込み

16644

広告

「"Wei AH"[Author]」の検索結果

71件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Impact of NPM1/FLT3-ITD genotypes defined by the2017 European LeukemiaNet in patients with acute myeloid leukemia.

How I treat acute myeloid leukemia in the era of new drugs.

Treatment practice and outcomes in mutant acute myeloid leukemia in the pre-midostaurin era: a real-world experience from Australian tertiary hospitals.

Net clinical benefit of non-vitamin K antagonist oral anticoagulants in atrial fibrillation and chronic kidney disease: a trade-off analysis from four phase III clinical trials.

Chromosomal Abnormalities and Prognosis in -Mutated Acute Myeloid Leukemia: A Pooled Analysis of Individual Patient Data From Nine International Cohorts.

Interconversion between Tumorigenic and Differentiated States in Acute Myeloid Leukemia.

Polyclonal Heterogeneity: The New Norm for Secondary Clinical Resistance to Targeted Monotherapy in Relapsed Leukemia?

Application of multiplex ligation-dependent probe amplification in the genetic testing of oculocutaneous albinism.

A network meta-analysis for safety of endothelin receptor antagonists in pulmonary arterial hypertension.

Net clinical benefit analysis of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and chronic kidney disease: Protocol for a systematic review and meta-analysis.

Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants-a Systematic Review and Meta-analysis.

Incorporating Precision BH3 Warheads Into the Offensive Against Acute Myeloid Leukemia.

Blinatumomab versus chemotherapy in first salvage or in later salvage for B-cell precursor acute lymphoblastic leukemia.

Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome.

Genomic subtyping and therapeutic targeting of acute erythroleukemia.

Maintenance therapy for AML: are we there yet?

Venetoclax Combined With Low-Dose Cytarabine for Previously Untreated Patients With Acute Myeloid Leukemia: Results From a Phase Ib/II Study.

New drugs creating new challenges in acute myeloid leukemia.

BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines.

HPLC analysis, optimization of extraction and purification conditions, biological evaluation of total protoflavones from Macrothelypteris viridifrons.

  1. 1
  2. 2
  3. 3
  4. 4
Sort by
※並べ替えは表示に時間がかかります